Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wound Care: Finding a Niche

Executive Summary

The relatively open nature of the wound care market has created a golden opportunity for manufacturers to step up and introduce a variety of new products, although rarely is new a signal of true innovation in this space. And that, in turn, has created a broad, diverse, and fragmented industry, as demonstrated by the packed exhibit hall at the April 2010 meeting of the Symposium on Advanced Wound Care and the Wound Healing Society.

You may also be interested in...

Biologics: The Growth Engine in Advanced Wound Care

With estimated revenues in excess of $5 billion per year worldwide, the advanced wound care market has garnered the attention of both major companies and investors for its tremendous potential. Growth in this market is being driven by the development of new bioactive products that can successfully heal chronic wounds such as diabetic foot ulcers, which are among the most challenging and costly to treat.

Targeting Acute Wounds with Advanced Technologies

Acute wound care will continue to evolve as hospitals face increasing pressure from payors and patient safety advocates to address the issue of surgical wounds and surgical site infections. CMS has added SSIs to the list of preventable, hospital-acquired conditions that it will no longer cover. A number of companies are seizing the opportunity to develop technologies that can help hospitals and patients avoid these costly conditions.

Wound Care Devices: Growth Amid Uncertainty

Over the last 15 years, a trend toward evidence-based medicine has led to a greater understanding of the science behind wound healing. This knowledge has fueled an explosion of innovation in technology and in the commercialization of a wide range of new products, generating a worldwide market estimated at $4.5 billion annually, with double-digit growth projected over the next three to five years.

Related Content


Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts